Skip to main content
SpringerLink
Log in

Aclarubicin/cytarabine/granulocyte colony-stimulating factors

Agranulocytosis: 16 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Xue S-L, et al. Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: A retrospective study of 25 Chinese patients. Hematological Oncology 31: 206-212, No. 4, Dec 2013. Available from: URL: http://doi.org/10.1002/hon.2051 - China

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aclarubicin/cytarabine/granulocyte colony-stimulating factors. Reactions Weekly 1502, 5 (2014). https://doi.org/10.1007/s40278-014-0887-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-0887-5

Search

Navigation